Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

10

Revenue 2017

Lyrica

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Lyrica was produced by Pfizer and Eisai.

Daiichi Sankyo starts mirogabalin trial in spinal injury pain

Daiichi Sankyo starts mirogabalin trial in spinal injury pain

rival to Pfizer’s big-selling Lyrica (pregabalin) brand which brought in $4.7bn last year despite generic competition in some markets. ... Like the original Lyrica formulation Daiichi Sankyo’s drug is dosed twice-daily.

The handover: Pfizer reshapes itself for a new era

The handover: Pfizer reshapes itself for a new era These new products will help offset the patent expiry of one of Pfizer’s biggest products, pain treatment Lyrica, which will see generics arrive at the end of December. ... autonomous. Created in the summer reshuffle, the Established Medicines division

Pfizer names next CEO as Read retires

Pfizer names next CEO as Read retires Nevertheless, the new CEO will undoubtedly consider the M&A market once he takes over in 2019, not least because of impending generic threats to $4bn a year blockbuster Lyrica sales

Pfizer builds gap between pharma and consumer health units

Pfizer builds gap between pharma and consumer health units The last of these – epilepsy therapy Lyrica (pregabalin) – will be exposed to generic competition in the US from December of this year, he said.

The good, the bad and the ugly

The good, the bad and the ugly Pfizer has large sales in CNS - $8.5bn in 2017. The majority come through Lyrica ($5bn). ... In Europe, a patent dispute over Lyrica became arguably the biggest CNS story in recent years.

1 2 3 4 5 6 7 8 9 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics